National Historical Income Statement
| NHC Stock | USD 122.83 0.34 0.28% |
Historical analysis of National HealthCare income statement accounts such as Gross Profit of 333.8 M can show how well National HealthCare performed in making a profits. Evaluating National HealthCare income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of National HealthCare's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining National HealthCare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether National HealthCare is a good buy for the upcoming year.
National |
About National Income Statement Analysis
National HealthCare Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to National HealthCare shareholders. The income statement also shows National investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
National HealthCare Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts National HealthCare generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of National HealthCare minus its cost of goods sold. It is profit before National HealthCare operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Cost Of Revenue
Cost of Revenue is found on National HealthCare income statement and represents the costs associated with goods and services National HealthCare provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from National HealthCare's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into National HealthCare current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National HealthCare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade National Stock refer to our How to Trade National Stock guide.At present, National HealthCare's Research Development is projected to increase slightly based on the last few years of reporting. The current year's Net Income From Continuing Ops is expected to grow to about 69.9 M, whereas Depreciation And Amortization is forecasted to decline to about 25.7 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 344.9M | 388.1M | 429.2M | 333.8M | Total Revenue | 1.0B | 1.1B | 1.1B | 710.2M |
National HealthCare income statement Correlations
Click cells to compare fundamentals
National HealthCare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
National HealthCare income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 42.4M | 42.0M | 40.7M | 40.5M | 42.0M | 25.7M | |
| Interest Expense | 3.1M | 1.4M | 845K | 563K | 324K | 307.8K | |
| Total Revenue | 996.4M | 980.7M | 1.0B | 1.1B | 1.1B | 710.2M | |
| Gross Profit | 403.6M | 371.4M | 344.9M | 388.1M | 429.2M | 333.8M | |
| Other Operating Expenses | 944.2M | 932.6M | 960.0M | 1.0B | 1.1B | 658.4M | |
| Operating Income | 78.9M | 48.2M | 50.9M | 31.9M | 57.1M | 51.8M | |
| Ebit | 78.9M | 53.8M | 150.9M | 27.8M | 89.1M | 57.4M | |
| Ebitda | 121.3M | 95.8M | 191.6M | 68.3M | 131.1M | 83.1M | |
| Cost Of Revenue | 592.8M | 609.3M | 666.1M | 686.2M | 712.3M | 376.4M | |
| Total Operating Expenses | 351.4M | 323.3M | 294.0M | 356.2M | 372.1M | 297.1M | |
| Net Income | 68.2M | 41.9M | 138.6M | 22.4M | 66.8M | 43.0M | |
| Income Tax Expense | 20.0M | 10.4M | 11.0M | 7.3M | 23.5M | 19.2M | |
| Selling General Administrative | 40.5M | 40.5M | 40.8M | 41.0M | 41.5M | 39.4M | |
| Income Before Tax | 88.0M | 52.4M | 150.0M | 27.2M | 88.7M | 67.4M | |
| Total Other Income Expense Net | 9.1M | 4.3M | 99.1M | (4.7M) | 31.6M | 18.7M | |
| Net Income Applicable To Common Shares | 68.2M | 41.9M | 138.6M | 22.4M | 25.8M | 47.1M | |
| Research Development | 0.09 | 0.05 | 0.15 | 0.03 | 0.08 | 0.084 | |
| Net Income From Continuing Ops | 55.7M | 66.0M | 153.0M | 20.0M | 65.3M | 69.9M | |
| Non Operating Income Net Other | 26.7M | 28.2M | 113.0M | 11.1M | 12.8M | 12.2M | |
| Minority Interest | (235K) | 119K | 497K | 2.5M | 1.5M | 1.6M | |
| Tax Provision | 20.0M | 10.4M | 11.0M | 7.3M | 23.5M | 15.0M | |
| Interest Income | 7.2M | 5.8M | 4.7M | 5.1M | 8.4M | 6.1M | |
| Net Interest Income | 4.1M | 4.4M | 3.8M | 4.6M | 8.1M | 4.2M | |
| Reconciled Depreciation | 42.4M | 42.0M | 40.7M | 40.5M | 42.0M | 33.4M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National HealthCare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.021 | Dividend Share 2.4 | Earnings Share 7.99 | Revenue Per Share 79.613 | Quarterly Revenue Growth 0.179 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.